Withaferin-A inhibition of AKT promoted nuclear localization of FOXO3a and induced apoptosis in prostate cancer cells, and Withaferin-A-induced apoptosis in prostate cancer cells was significantly affected when AKT was overexpressed or FOXO3a was silenced [45]. The gene discussed is AKT1; the disease is prostate carcinoma.